New Delhi: Human trial of a new COVID-19 vaccine developed by researchers at University of Oxford to begin from 23rd April, the UK government announced on Wednesday.
The researchers at University of Oxford have been successful in developing a super-fast vaccine to treat the disease caused by SARS-Cov-2 virus and according to lead professor Sarah Gilbert, the vaccine will be available in market by September.
The health secretary of United Kingdom Matt Hancock during a press conference held recently also announced that the government will allot 20 million pounds to the university’s research team to help fund their clinical trials.
“The team has accelerated that trials process, working with the regulator the MHRA (Medicines and Healthcare Regulatory Agency), who have been brilliant. As a result, I can announce that the vaccine from the Oxford project will be trialled in people from this Thursday,” said Hancock during the press conference
A member of the Oxford vaccine research team while speaking to an international media said, “If you had a sailing wind and absolutely nothing goes wrong in all of that complex technical process and you have all the facilities available, you could have millions of doses by the autumn of this year.”
In a normal procedure, research and development of a vaccine takes anywhere from 12 to 18 months but the vaccine developed by researchers at University of Oxford promises to supply the medicine in record time.
The Indian Council of Medical Research (ICMR) has also lauded the efforts of University of Oxford terming it as the frontrunner in the race to take on the deadly coronavirus.